Rock Creek Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-542
Closed -$291K 126
2023
Q3
$291K Sell
542
-456
-46% -$235K 0.04% 71
2023
Q2
$468K Buy
998
+288
+41% +$121K 0.07% 60
2023
Q1
$244K Sell
710
-212
-23% -$71.5K 0.03% 86
2022
Q4
$337K Buy
922
+286
+45% +$101K 0.04% 70
2022
Q3
$206K Buy
636
+276
+77% +$87.4K 0.03% 86
2022
Q2
$117K Buy
360
+69
+24% +$20.7K 0.01% 109
2022
Q1
$83K Sell
291
-620
-68% -$160K 0.01% 131
2021
Q4
$252K Buy
911
+49
+6% +$12.4K 0.04% 128
2021
Q3
$199K Sell
862
-429
-33% -$106K 0.03% 106
2021
Q2
$296K Buy
1,291
+340
+36% +$68.3K 0.04% 124
2021
Q1
$178K Sell
951
-750
-44% -$147K 0.03% 129
2020
Q4
$287K Sell
1,701
-2,263
-57% -$338K 0.12% 119
2020
Q3
$587K Buy
3,964
+1,593
+67% +$247K 0.3% 79
2020
Q2
$389K Buy
+2,371
New +$364K 0.21% 93
2019
Q1
Sell
-9,328
Closed -$1.08M 100
2018
Q4
$1.08M Buy
+9,328
New +$1.04M 0.47% 44

Other funds holding LLY

Rock Creek Group's LLY Position: Q4 2023 in Review

Rock Creek Group sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 542 shares — an estimated $291K sold.

Rock Creek Group first reported a position in LLY in Q4 2018 and held it in 15 quarters. The position peaked at $1.08M in Q4 2018. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Rock Creek Group reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 542 Eli Lilly shares in Q4 2023, an estimated $291K.
  • Rock Creek Group first reported a position in Eli Lilly in Q4 2018 and held it in 15 quarters.
  • Rock Creek Group's Eli Lilly position peaked at $1.08M in Q4 2018.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.